Article Versions Notes

Assmus F, Driouich J-S, Abdelnabi R, Vangeel L, Touret F, Adehin A, Chotsiri P, Cochin M, Foo CS, Jochmans D, et al. Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19. Microorganisms. 2022; 10(8):1639. https://doi.org/10.3390/microorganisms10081639

Assmus, Frauke, Jean-Sélim Driouich, Rana Abdelnabi, Laura Vangeel, Franck Touret, Ayorinde Adehin, Palang Chotsiri, Maxime Cochin, Caroline S. Foo, Dirk Jochmans, and et al. 2022. "Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19" Microorganisms 10, no. 8: 1639. https://doi.org/10.3390/microorganisms10081639

Assmus, F., Driouich, J.-S., Abdelnabi, R., Vangeel, L., Touret, F., Adehin, A., Chotsiri, P., Cochin, M., Foo, C. S., Jochmans, D., Kim, S., Luciani, L., Moureau, G., Park, S., Pétit, P.-R., Shum, D., Wattanakul, T., Weynand, B., Fraisse, L., ... Chatelain, E. (2022). Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19. Microorganisms, 10(8), 1639. https://doi.org/10.3390/microorganisms10081639